The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.
Amedisys, Inc. is being acquired by UnitedHealth ... They share the DOJ’s concern: by being both an insurer and a provider, UnitedHealth will undermine competition and consumer choice.
Leaders at UnitedHealth Group and Amedisys are set to meet with the Department of Justice (DOJ) this week in hopes of avoiding a potential attempt to block their $3.3 billion merger deal ...
Home health company Amedisys, based in Louisiana and Nashville, fell short of estimates in its third quarter earnings report.
UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to ...
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Amedisys, Inc. (Symbol: AMED) entered into oversold territory, hitting an RSI reading of ...
UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers in a last-ditch effort to persuade the agency not to challenge their ...
Amedisys (AMED) came out with quarterly earnings of $1 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $0.98 per share a year ago. These figures are ...
BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care ...
This home health care and hospice services provider has seen a nice streak ... For the most recent quarter, Amedisys was expected to post earnings of $1.22 per share, but it reported $1.32 per ...
Amedisys: Amedisys, a well-known provider of home health, hospice and high-acuity care, reported its second-quarter 2024 results in July. The company recorded an uptick in its overall net service ...
Non-Medicare and high-acuity care revenue continue to grow substantially at Amedisys Inc. (Nasdaq: AMED). While the company waits to become a part of UnitedHealth Group (NYSE: UNH) – in a $3.3 billion ...